Gray, Daniel H.D.

The Immunological Genome Project: networks of gene expression in immune cells

The Immunological Genome Project Consortium, Heng, T. S. P., Painter, M. W., Elpek, K., Lukacs-Kornek, V., Mauermann, N., Turley, S. J., Koller, D., Kim, F. S., Wagers, A. J., et al. (2008) · Nature Immunology

Bioinformatics and Genomic NetworksGenomics and Chromatin Dynamics

Cited by 1,864

XIAP discriminates between type I and type II FAS-induced apoptosis

Jost, P. J., Grabow, S., Gray, D., McKenzie, M. D., Nachbur, U., Huang, D. C. S., Bouillet, P., Thomas, H. E., Borner, C., Silke, J., et al. (2009) · Nature

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 482

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Blombery, P., Anderson, M. A., Gong, J.-N., Thijssen, R., Birkinshaw, R. W., Thompson, E. R., Teh, C. E., Nguyen, T., Xu, Z., Flensburg, C., et al. (2019) · Cancer Discovery

Chronic Lymphocytic Leukemia ResearchCell death mechanisms and regulation

Cited by 434

Mesenchymal stromal cell apoptosis is required for their therapeutic function

Pang, S. H. M., D’Rozario, J., Mendonca, S., Bhuvan, T., Payne, N. L., Zheng, D., Hisana, A., Wallis, G., Barugahare, A., Powell, D., et al. (2021) · Nature Communications

Mesenchymal stem cell researchCell death mechanisms and regulation

Cited by 245

Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration.

Alpdogan, O., Hubbard, V. M., Smith, O. M., Patel, N., Lu, S., Goldberg, G. L., Gray, D. H., Feinman, J., Kochman, A. A., Eng, J. M., et al. (2006) · Blood

Hematopoietic Stem Cell TransplantationT-cell and B-cell Immunology

Cited by 220

Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment

Best, S. A., De Souza, D. P., Kersbergen, A., Policheni, A. N., Dayalan, S., Tull, D., Rathi, V., Gray, D. H., Ritchie, M. E., McConville, M. J., et al. (2018) · Cell Metabolism

Genomics, phytochemicals, and oxidative stressFerroptosis and cancer prognosis

Cited by 217

Effects of Castration on Thymocyte Development in Two Different Models of Thymic Involution

Heng, T. S. P., Goldberg, G. L., Gray, D. H. D., Sutherland, J. S., Chidgey, A. P., & Boyd, R. L. (2005) · The Journal of Immunology

T-cell and B-cell ImmunologyHematopoietic Stem Cell Transplantation

Cited by 216

VDAC2 enables BAX to mediate apoptosis and limit tumor development

Chin, H. S., Li, M. X., Tan, I. K. L., Ninnis, R. L., Reljic, B., Scicluna, K., Dagley, L. F., Sandow, J. J., Kelly, G. L., Samson, A. L., et al. (2018) · Nature Communications

Cell death mechanisms and regulationMitochondrial Function and Pathology

Cited by 196

A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2-positive metastatic breast cancer

Lok, S. W., Whittle, J. R., Vaillant, F., Teh, C. E., Lo, L. L., Policheni, A. N., Bergin, A. R. T., Desai, J., Ftouni, S., Gandolfo, L. C., et al. (2019) · Cancer Discovery

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 148

Dual targeting of CDK4/6 and BCL2 pathways augments tumor response in estrogen receptor-positive breast cancer

Whittle, J. R., Vaillant, F., Surgenor, E., Policheni, A. N., Giner, G., Capaldo, B. D., Chen, H.-R., Liu, H. K., Dekkers, J. F., Sachs, N., et al. (2020) · Clinical Cancer Research

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 102

Removing unwanted variation with CytofRUV to integrate multiple CyTOF datasets

Trussart, M., Teh, C. E., Tan, T., Leong, L., Gray, D. H., & Speed, T. P. (2020) · eLife

Single-cell and spatial transcriptomicsAdvanced Proteomics Techniques and Applications

Cited by 51